VIVUS to Host First Quarter Business Update and Financial Results Conference Call on Tuesday, April 30, 2019
VIVUS, Inc. (Nasdaq: VVUS) today announced that it will report
financial results and provide a business update for the first
quarter of 2019 after the market close on Tuesday, April 30, 2019.
The company will host a conference call beginning at 4:30 p.m. ET /
1:30 p.m. PT the same day to review results and provide a business
To listen via webcast, please visit http://ir.vivus.com/, or by
To listen via phone, please use the dial in information provided
Dial in Details:Toll-Free: (877) 359-2916International: (224)
A webcast replay will be available on
the VIVUS website for 30 days.
About VIVUSVIVUS is a biopharmaceutical company
committed to the development and commercialization of innovative
therapies that focus on advancing treatments for patients with
serious unmet medical needs. For more information about the
Company, please visit www.vivus.com.
Certain statements in this press release are forward-looking
within the meaning of the Private Securities Litigation Reform Act
of 1995. These statements may be identified by the use of
forward-looking words such as “anticipate,” “believe,” “forecast,”
“estimate,” “expect,” “intend,” “likely,” “may,” “plan,”
“potential,” “predict,” “opportunity” and “should,” among others.
There are a number of factors that could cause actual events to
differ materially from those indicated by such forward-looking
statements. VIVUS does not undertake an obligation to update or
revise any forward-looking statements. Investors should read the
risk factors set forth in VIVUS’ Form 10-K for the year ended
December 31, 2018 as filed on February 26, 2019, and periodic
reports filed with the Securities and Exchange Commission. VIVUS
does not undertake an obligation to update or revise any
Chief Financial Officer firstname.lastname@example.org